{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:50:31Z","timestamp":1792504231629,"version":"4.5.0"},"reference-count":77,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T00:00:00Z","timestamp":1269475200000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>Correll CU, Sheridan EM, DelBello MP. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo\u2010controlled trials.\u2028Bipolar Disord 2010: 12: 116\u2013141. \u00a9 2010 The Authors.\u2028Journal compilation \u00a9 2010 John Wiley &amp; Sons A\/S.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective:\u2002<\/jats:bold>\n                    To compare antipsychotic and mood stabilizer (MS) efficacy and tolerability in youth and adults with bipolar mania.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:\u2002<\/jats:bold>\n                    Medline\/PubMed search for studies including: (i) youth (&lt; 18\u2003years) or adults (\u2265 18\u2003years); (ii) bipolar I disorder; (iii) double\u2010blind, randomized, placebo\u2010controlled trial (DB\u2010RPCT); (iv) \u2264 12\u2003weeks of treatment; and (v) calculable effect sizes (ES) and\/or numbers needed to treat\/harm (NNT\/NNH)\u2003\u00b1\u200395% confidence intervals (CI). Non\u2010overlapping 95% CIs determined significant group differences.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    We identified nine DB\u2010RPCTs in youth (n\u2003=\u20031,609), 5 evaluating second\u2010generation antipsychotics (SGAs) (n\u2003=\u20031,140) and 4 evaluating MSs (n\u2003=\u2003469). We also identified 23 DB\u2010RPCTs in adults (n\u2003=\u20036,501), 14 including SGAs (n\u2003=\u20033,297), 5 using haloperidol as an active comparator (n\u2003=\u2003580), and 11 including MSs (n\u2003=\u20032,581). Young Mania Rating Scale scores improved significantly more with SGAs than MSs in youth (ES\u2003=\u20030.65, CI: 0.53\u20130.78 versus 0.24, CI: 0.06\u20130.41) and adults (ES\u2003=\u20030.48, CI: 0.41\u20130.55 versus 0.24, CI: 0.17\u20130.31). After excluding topiramate studies, SGAs had larger ES than MSs only in youth (ES\u2003=\u20030.65, CI: 0.53\u20130.78 versus 0.20, CI: 0.02\u20130.39), but not adults (ES\u2003=\u20030.48, CI: 0.41\u20130.55 versus 0.46, CI: 0.37\u20130.55). However, in adults SGAs had significantly larger ES regarding Clinical Global Impressions scores than MSs, even without topiramate (ES\u2003=\u20030.75, CI: 0.68\u20130.82 versus 0.24, CI: 0.07\u20130.41). Rates of response, remission, and discontinuation due to any reason compared to placebo were similar between medication and age groups, except for more favorable NNTs for remission with SGAs than MSs in adults after excluding topiramate. SGAs caused more weight gain than MSs in youth (ES\u2003=\u20030.53, CI: 0.41\u20130.66 versus 0.10, CI: \u22120.12\u20130.33), but not in adults (ES\u2003=\u20030.13, CI: 0.05\u20130.22 versus 0.00, CI: \u22120.08\u20130.08). However, results were heterogeneous and not significant in either age group after excluding topiramate. Nevertheless, SGA\u2010related weight gain was significantly greater in youth than adults. In youth, SGA\u2010related somnolence was greater than with MSs (NNH\u2003=\u20034.7, CI: 3.9\u20136.0 versus 9.5, CI: 6.3\u201323.5), and more likely than in adults (NNH\u2003=\u20037.1, CI: 6.1\u20138.8). Conversely, youth experienced less akathisia with SGAs than adults (NNH\u2003=\u200320.4, CI: 14.1\u201336.5 versus 10.2, CI: 8.1\u201313.7), likely due to lower doses\/slower titration.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:\u2002<\/jats:bold>\n                    In treating mania, potentially greater short\u2010term efficacy compared to placebo with SGAs versus MS needs to be balanced against increased adverse events, especially in youth.\n                  <\/jats:p>","DOI":"10.1111\/j.1399-5618.2010.00798.x","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T07:55:24Z","timestamp":1269503724000},"page":"116-141","source":"Crossref","is-referenced-by-count":187,"title":["Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo\u2010controlled trials"],"prefix":"10.1111","volume":"12","author":[{"given":"Christoph U","family":"Correll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa P","family":"DelBello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.6.679"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.16.2673"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0954579406060597"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200503000-00006"},{"issue":"1","key":"e_1_2_5_6_2","first-page":"1","article-title":"Second\u2010generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer JW","year":"2005","journal-title":"CNS Drugs"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e318040b25f"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e31815b5cb1"},{"issue":"4","key":"e_1_2_5_9_2","first-page":"26","article-title":"Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents","volume":"69","author":"Correll CU","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.16.1867"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021423"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-0220"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.1.204"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035698"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.11.1471"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072515"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1214"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.0037"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1215"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chc.2005.08.007"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.06.016"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.17.2277"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802515"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.9.1032"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.11.006"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.2.213"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.2.307"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.4.582"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00247.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.01.022"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.5.459"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.3.430"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.08.042"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06101619"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.10.1125"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.7.1179"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0405"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0308"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/ebm.10.5.133"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7168.1309"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05164yel"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06111932"},{"key":"e_1_2_5_43_2","volume-title":"Presented at the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry","author":"DelBello MP","year":"2007"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2009.00750.x"},{"key":"e_1_2_5_45_2","volume-title":"Presented at the 63rd Annual Meeting of the Society of Biological Psychiatry","author":"DelBello MP","year":"2008"},{"key":"e_1_2_5_46_2","volume-title":"Presented 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry","author":"Kowatch RA","year":"2007"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e31819c55ec"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000159151.75345.20"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106059693"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.05.014"},{"key":"e_1_2_5_52_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.049965"},{"key":"e_1_2_5_53_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen M","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0116"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.02.006"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.6.1057"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.3.229"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2004.06.003"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.741"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169068.34322.70"},{"key":"e_1_2_5_62_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108099418"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"e_1_2_5_65_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n1003"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00276.x"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.112.1.155"},{"key":"e_1_2_5_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01194.x"},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004052"},{"key":"e_1_2_5_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000220851.94392.30"},{"key":"e_1_2_5_71_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790090075012"},{"key":"e_1_2_5_72_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.596"},{"key":"e_1_2_5_73_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m03538"},{"key":"e_1_2_5_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200402000-00018"},{"key":"e_1_2_5_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.05.027"},{"key":"e_1_2_5_76_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000194567.63289.97"},{"key":"e_1_2_5_77_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"key":"e_1_2_5_78_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000242240.69678.c4"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2010.00798.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2010.00798.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:09:07Z","timestamp":1698732547000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2010.00798.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1399-5618.2010.00798.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2010.00798.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}